Structural basis for the inhibition of human alkyladenine DNA by 3,N4-ethenocytosine containing DNA

Reactive oxygen and nitrogen species, generated by neutrophils and macrophages in chronically inflamed tissues, readily damage DNA, producing a variety of potentially genotoxic etheno base lesions; such inflammation-related DNA damage is now known to contribute to carcinogenesis. Although the human...

Full description

Bibliographic Details
Main Authors: Lingaraju, Gondichatnahalli M., Davis, Christopher A., Setser, Jeremy Wayne, Samson, Leona D, Drennan, Catherine L
Other Authors: Massachusetts Institute of Technology. Center for Environmental Health Sciences
Format: Article
Language:en_US
Published: American Society for Biochemistry and Molecular Biology, Inc. 2011
Online Access:http://hdl.handle.net/1721.1/64727
https://orcid.org/0000-0001-5486-2755
https://orcid.org/0000-0002-7112-1454
_version_ 1826207698067128320
author Lingaraju, Gondichatnahalli M.
Davis, Christopher A.
Setser, Jeremy Wayne
Samson, Leona D
Drennan, Catherine L
author2 Massachusetts Institute of Technology. Center for Environmental Health Sciences
author_facet Massachusetts Institute of Technology. Center for Environmental Health Sciences
Lingaraju, Gondichatnahalli M.
Davis, Christopher A.
Setser, Jeremy Wayne
Samson, Leona D
Drennan, Catherine L
author_sort Lingaraju, Gondichatnahalli M.
collection MIT
description Reactive oxygen and nitrogen species, generated by neutrophils and macrophages in chronically inflamed tissues, readily damage DNA, producing a variety of potentially genotoxic etheno base lesions; such inflammation-related DNA damage is now known to contribute to carcinogenesis. Although the human alkyladenine DNA glycosylase (AAG) can specifically bind DNA containing either 1,N6-ethenoadenine (ϵA) lesions or 3,N4-ethenocytosine (ϵC) lesions, it can only excise ϵA lesions. AAG binds very tightly to DNA containing ϵC lesions, forming an abortive protein-DNA complex; such binding not only shields ϵC from repair by other enzymes but also inhibits AAG from acting on other DNA lesions. To understand the structural basis for inhibition, we have characterized the binding of AAG to DNA containing ϵC lesions and have solved a crystal structure of AAG bound to a DNA duplex containing the ϵC lesion. This study provides the first structure of a DNA glycosylase in complex with an inhibitory base lesion that is induced endogenously and that is also induced upon exposure to environmental agents such as vinyl chloride. We identify the primary cause of inhibition as a failure to activate the nucleotide base as an efficient leaving group and demonstrate that the higher binding affinity of AAG for ϵC versus ϵA is achieved through formation of an additional hydrogen bond between Asn-169 in the active site pocket and the O2 of ϵC. This structure provides the basis for the design of AAG inhibitors currently being sought as an adjuvant for cancer chemotherapy.
first_indexed 2024-09-23T13:53:34Z
format Article
id mit-1721.1/64727
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T13:53:34Z
publishDate 2011
publisher American Society for Biochemistry and Molecular Biology, Inc.
record_format dspace
spelling mit-1721.1/647272022-10-01T17:49:17Z Structural basis for the inhibition of human alkyladenine DNA by 3,N4-ethenocytosine containing DNA Lingaraju, Gondichatnahalli M. Davis, Christopher A. Setser, Jeremy Wayne Samson, Leona D Drennan, Catherine L Massachusetts Institute of Technology. Center for Environmental Health Sciences Massachusetts Institute of Technology. Department of Biological Engineering Massachusetts Institute of Technology. Department of Biology Massachusetts Institute of Technology. Department of Chemistry Koch Institute for Integrative Cancer Research at MIT Drennan, Catherine L. Drennan, Catherine L. Samson, Leona D. Setser, Jeremy Wayne Davis, Christopher A. Lingaraju, Gondichatnahalli M. Reactive oxygen and nitrogen species, generated by neutrophils and macrophages in chronically inflamed tissues, readily damage DNA, producing a variety of potentially genotoxic etheno base lesions; such inflammation-related DNA damage is now known to contribute to carcinogenesis. Although the human alkyladenine DNA glycosylase (AAG) can specifically bind DNA containing either 1,N6-ethenoadenine (ϵA) lesions or 3,N4-ethenocytosine (ϵC) lesions, it can only excise ϵA lesions. AAG binds very tightly to DNA containing ϵC lesions, forming an abortive protein-DNA complex; such binding not only shields ϵC from repair by other enzymes but also inhibits AAG from acting on other DNA lesions. To understand the structural basis for inhibition, we have characterized the binding of AAG to DNA containing ϵC lesions and have solved a crystal structure of AAG bound to a DNA duplex containing the ϵC lesion. This study provides the first structure of a DNA glycosylase in complex with an inhibitory base lesion that is induced endogenously and that is also induced upon exposure to environmental agents such as vinyl chloride. We identify the primary cause of inhibition as a failure to activate the nucleotide base as an efficient leaving group and demonstrate that the higher binding affinity of AAG for ϵC versus ϵA is achieved through formation of an additional hydrogen bond between Asn-169 in the active site pocket and the O2 of ϵC. This structure provides the basis for the design of AAG inhibitors currently being sought as an adjuvant for cancer chemotherapy. United States. Dept. of Energy (Contract Number DE-AC02-05CH11231) David H. Koch Institute for Integrative Cancer Research at MIT (Graduate Fellowship) Repligen Corporation National Institutes of Health (U.S.) (Grant P30-ES002109) National Institutes of Health (U.S.) (grant GM65337) National Institutes of Health (U.S.) (grant GM65337) National Institutes of Health (U.S.) (Grant CA055042) National Institutes of Health (U.S.) (Grant CA055042) 2011-06-30T18:29:55Z 2011-06-30T18:29:55Z 2011-04 2011-02 Article http://purl.org/eprint/type/JournalArticle 0021-9258 1083-351X http://hdl.handle.net/1721.1/64727 Lingaraju, Gondichatnahalli M. et al. “Structural Basis for the Inhibition of Human Alkyladenine DNA Glycosylase (AAG) by 3,N4-Ethenocytosine-containing DNA.” Journal of Biological Chemistry 286.15 (2011) : 13205 -13213. © 2011 by American Society for Biochemistry and Molecular Biology. https://orcid.org/0000-0001-5486-2755 https://orcid.org/0000-0002-7112-1454 en_US http://dx.doi.org/10.1074/jbc.M110.192435 Journal of Biological Chemistry Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf American Society for Biochemistry and Molecular Biology, Inc. Prof. Drennan via Erja Kajosalo
spellingShingle Lingaraju, Gondichatnahalli M.
Davis, Christopher A.
Setser, Jeremy Wayne
Samson, Leona D
Drennan, Catherine L
Structural basis for the inhibition of human alkyladenine DNA by 3,N4-ethenocytosine containing DNA
title Structural basis for the inhibition of human alkyladenine DNA by 3,N4-ethenocytosine containing DNA
title_full Structural basis for the inhibition of human alkyladenine DNA by 3,N4-ethenocytosine containing DNA
title_fullStr Structural basis for the inhibition of human alkyladenine DNA by 3,N4-ethenocytosine containing DNA
title_full_unstemmed Structural basis for the inhibition of human alkyladenine DNA by 3,N4-ethenocytosine containing DNA
title_short Structural basis for the inhibition of human alkyladenine DNA by 3,N4-ethenocytosine containing DNA
title_sort structural basis for the inhibition of human alkyladenine dna by 3 n4 ethenocytosine containing dna
url http://hdl.handle.net/1721.1/64727
https://orcid.org/0000-0001-5486-2755
https://orcid.org/0000-0002-7112-1454
work_keys_str_mv AT lingarajugondichatnahallim structuralbasisfortheinhibitionofhumanalkyladeninednaby3n4ethenocytosinecontainingdna
AT davischristophera structuralbasisfortheinhibitionofhumanalkyladeninednaby3n4ethenocytosinecontainingdna
AT setserjeremywayne structuralbasisfortheinhibitionofhumanalkyladeninednaby3n4ethenocytosinecontainingdna
AT samsonleonad structuralbasisfortheinhibitionofhumanalkyladeninednaby3n4ethenocytosinecontainingdna
AT drennancatherinel structuralbasisfortheinhibitionofhumanalkyladeninednaby3n4ethenocytosinecontainingdna